The next-generation Visiflex Delivery System from Endologix is FDA approved to be marketed for use with the Powerlink system for the minimally invasive treatment of abdominal aortic aneurysms. Full U.S. commercialization is anticipated this fall.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now